Clinical trial
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302
NCT07762638 is registered in ClinicalTrials.gov with Idorsia Pharmaceuticals Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.
- Phase
- Expanded access
- Overall status
- Available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.